Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10375 |
| Vaccine Name | OMB157 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | RNA based vaccine |
| Vaccine Status | Phase 4 |
| Manufacturer | Novartis |
| Year of Manufacturing | 2021 |
| Manufacturing Country | Germany |
| Age | 18 years and above |
| Dosage | NA |
| Administration Route | Subcutaneous |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | Ofatumumab |
| PMID | NA |
| Clinical Trial ID | NCT04869358 |
| Reference Link | https://clinicaltrials.gov/show/NCT04869358 |
| Additional Links | https://www.ema.europa.eu/en/documents/assessment-report/kesimpta-epar-public-assessment-report_en.pdf |